| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
REVIEW SERIES |
1-Antitrypsin deficiency · 6: New and emerging treatments for 1-antitrypsin deficiency
National Jewish Medical and Research Center, Denver, Colorado, and AlphaNet Inc, Miami, Florida, USA
Correspondence to:
Correspondence to:
Dr R Sandhaus
Professor of Medicine, Director, Alpha-1 Program, National Jewish Medical and Research Center, Southside Building G106, 1400 Jackson Street, Denver, CO 80206, USA; rasandhaus{at}alphaone.org
Alpha-1-antitrypsin (AAT) deficiency is a genetic condition that increases the risk of developing lung and liver disease, as well as other associated conditions. Most treatment of affected individuals is not specifically directed at AAT deficiency but focuses on the resultant disease state. The only currently available specific therapeutic agent—namely, intravenous augmentation with plasma derived AAT protein—is marketed in a limited number of countries. Treatments aimed at correcting the underlying genetic abnormality, supplementing or modifying the gene product, and halting or reversing organ injury are now beginning to emerge. These innovative approaches may prove effective at modifying or eliminating diseases association with AAT deficiency.
Keywords: 
1-antitrypsin deficiency; treatment
Relevant Article
Thorax 2004 59: 821a.
This article has been cited by other articles:
|
|
 |
|
  B. R. Celli Update on the Management of COPD Chest, June 1, 2008; 133(6): 1451 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Zamora, R. V. Pla, P. G. Del Rio, R. J. Margaleff, F. R. Frias, and J. B. M. Ronsano Intravenous Human Plasma-Derived Augmentation Therapy in {alpha}1-Antitrypsin Deficiency: From Pharmacokinetic Analysis to Individualizing Therapy Ann. Pharmacother., May 1, 2008; 42(5): 640 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Trotta, A. V. Stolin, M. B. Williams, S. B. Gay, A. S. Brody, and T. A. Altes Characterization of the Relation Between CT Technical Parameters and Accuracy of Quantification of Lung Attenuation on Quantitative Chest CT Am. J. Roentgenol., June 1, 2007; 188(6): 1683 - 1690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J A Wedzicha, E C Howard, S L Johnston, and D M Mitchell Thorax Annual Report October 2004-September 2005 Thorax, December 1, 2005; 60(12): 987 - 988. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Barnes and R. A. Stockley COPD: current therapeutic interventions and future approaches Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Fishman One Hundred Years of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 941 - 948. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
